She was fearless.

Amygdala not the only gatekeeper of dread in human mind When doctors in the University of Iowa prepared a patient to inhale a panic-inducing dose of skin tightening and, she was fearless . But within minutes of breathing in the mixture, she cried for help, overwhelmed by the sensation that she was suffocating. The patient, a woman in her 40s referred to as SM, comes with an extremely rare condition known as Urbach-Wiethe disease which has caused extensive damage to the amygdala, an almond-shaped region in the mind long known because of its role in dread. She hadn’t felt terror since getting the disease when she was an adolescent.

Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical research for combating sleeping sickness Anacor Pharmaceuticals , the Drugs for Neglected Diseases initiative , and SCYNEXIS Inc. Today announced the successful completion of pre-clinical studies for the first new oral drug applicant discovered specifically to fight individual African trypanosomiasis , known as sleeping sickness also. Today in the open-gain access to journal PLoS Neglected Tropical Illnesses An article released, reveals the original successful results of pre-clinical research of the new compound, that will soon advance to Phase I human scientific trials.